OMNIAB, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
OMNIAB, INC. (OABI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $3.16M, a 23.16% decline year-over-year.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $3.34M, a 19.40% decline year-over-year.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.96M, a 25.30% decline year-over-year.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $4.11M, a 23.63% decline year-over-year.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $15.82M, a 26.40% decline from fiscal 2024.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $21.50M, a 13.38% decline from fiscal 2023.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $24.82M, a 540.02% increase from fiscal 2022.
- OMNIAB, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.88M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.16M 10-Q · filed 2026-08-06 | $6.50M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $3.34M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $15.82M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $3.96M 10-Q · filed 2025-11-04 | $8.07M derived: sum of 2 quarters · filed 2026-08-06 | $12.22M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $4.11M 10-Q · filed 2026-08-06 | $8.26M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $4.14M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $21.50M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $5.30M 10-Q · filed 2025-11-04 | $10.69M derived: sum of 2 quarters · filed 2025-11-04 | $16.38M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $5.38M 10-Q · filed 2025-11-04 | $11.08M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $5.70M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $24.82M 10-K · filed 2025-03-18 | |||
| 2023-09-30 | $6.31M 10-Q · filed 2024-11-12 | $12.84M derived: sum of 2 quarters · filed 2024-11-12 | $18.89M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $6.53M 10-Q · filed 2024-11-12 | $12.58M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $6.05M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $3.88M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |